In February took place the first round of selection of the Softlanding Program in Boston organised by Medicen Paris Region, Bpifrance, French Tech Hub, MedNest and Massmedic Council. A high number of startups and SMEs applied to the call, but only 8 of them will come to Boston during MassMedicWeek on May 1-5.
Initially, a group of 13 companies were chosen out of 24 startups and SMES that applied. They had the opportunity to pitch to a bilateral expert judging panel composed of healthcare experts, investors and representatives of innovation organizations from Paris and Boston, such as Brown Rudnick, Acceleration International and Bpifrance. In the second round, eight companies were selected based on their innovative solutions, team expertise and business potential for the US market.
Check below the list of the 8 winners:
- BioSerenity launched Neuronaute, a mobile EEG system using smart clothing that allows for long term monitoring of EEG signals in order to help with the diagnosis of epilepsy
- DAMAE Medical provides dermatologists with a new in vivo imaging modality capable of producing in-depth images of the tissue, similar to histology without the need for skin tissue excision and processing
- DeepOR: Time is a scarce resource in hospital Operating Rooms (ORs). DeepOR offers an innovative solution in automating workflow management and monitoring real-time activity in the OR. Thanks to DeepOR’s artificial intelligence, medical staff can focus on caregiving and more patients have access to surgery.
- Microbrain Biotech develops and designs microfluidic devices and Nerve-on-Chip (reconstructed neuron networks at the micron scale). Microbrain offers new approaches for evaluation and screening of molecules (compartmentalized pharmacology, functional networks)
- Neurallys develops a smart sensor offering continuous measurement of intracranial pressure for patients living with hydrocephalus to diagnose valve dysfunction, increasing patient comfort and preventing exploratory surgeries for people who have a shunt
- RYTHM applied years of neuroscience research and combined it with advanced technology to develop an active sleep wearable device, allowing improvement in sleep quality through brain auditory stimulations
- SURICOG develops an innovative and turnkey eye-tracking medical device. This recognized solution, used by 50+ medical centers, assists practitioners in the diagnosis of neurological and psychiatric diseases. Using its proprietary eye interactivity technology, SURICOG is committed to developing new digital therapies dedicated to brain diseases
- Tongue Lab develops the first oral devices for curative treatment of snoring and obstructive sleep apnea, improving sports performance and the sense of wellness on awakening.
Subscribe to our newsletter if you want to keep you updated with the next phases of the program!